Skip to main content
. 2016 Jun 23;115(2):236–242. doi: 10.1038/bjc.2016.169

Figure 2.

Figure 2

Ki67 and DLX2 are predictive biomarkers of disease progression risk in prostate cancer.Kaplan–Meier plots demonstrating (A) prostate-specific cancer death over time according to Ki67 score. (B) metastasis development over time according to Ki67 score. (C) prostate-specific cancer death over time according to DLX2 score. (D) metastasis development over time according to DLX2 score.